THE CONAFAY GROUP, LLC

Lobbying for CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP · Representing the voice of emerging antibiotics industry

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · North Carolina · House · Senate · $60,000.00 income · posted Apr 18, 2025

Lobbying activity 1

Health Issues

Legislation related to antimicrobial resistance(AMR), reimbursement reform, CURES Act 2.0 and FY26 Appropriations and PAHPA.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.